The table below shows Cullinan Therapeutics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
$0.00
$18.94M
$0.00
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$187.40M
$142.90M
$148.16M
$91.95M
$57.75M
$43.21M
SG&A
CGEM annual revenue (10-K history)
Cullinan Therapeutics, Inc. reported annual revenue of $0.00 for fiscal year 2022. That is down 100.0% from $18.94M in fiscal 2021. Figures come from the company's audited annual reports as filed with the SEC.
